Sarcoid-like reactions occur in a small percentage of cancer patients. This reaction causeslymph nodes to appear hypermetabolic when viewed with Fludeoxyglucose-Positron EmissionTomography (FDG-PET). This is clinically important, because it could be confused with tumormetastasis and could affect the staging and treatment of the cancer. In addition to sarcoid-likereactions and metastasis, several other disease processes can cause lymph nodes to appearhypermetabolic with FDG-PET, including coal worker’s pneumoconiosis. We present the caseof a 61-year-old coal miner who was diagnosed with lung cancer. FDG-PET showed increaseduptake in ipsilateral and contralateral mediastinal lymph. The patient had bronchoscopy withendobronchial ultrasound (EBUS) guided biopsy of the mass and needle aspiration of bilaterallymph nodes of the mediastinum. All the biopsies were negative. The patient then had a leftupper lobectomy and left mediastinal lymph node dissection. The PET findings were originallyattributed to metastasis of the tumor, but pathology of the ipsilateral nodes showed silicoticchanges due to pneumoconiosis and non-caseating granulomas from a sarcoid-like reaction.Because the ipsilateral lymph nodes had no evidence of metastasis and EBUS biopsy ofthe contralateral nodes was negative, it was unlikely that the changes in the contralateralnodes were due to metastasis, and no adjuvant treatment was offered. At more than oneyear after surgery, the patient remains stable with no evidence of recurrence, and we haveclinical assurance that the changes in the lymph nodes were due to the sarcoid-like reactionand pneumoconiosis and not metastasis. FDG-PET is useful for detection of lung cancer, butpathology is necessary for staging and determining treatment for the patient.